In conclusion, based on the Japan MS/NMOSD Biobank data, we show HLA genotype-clinical phenotype correlations concerning the confirmed and newly identified susceptibility and resistance DRB1 and DPB1 genes in Japanese patients with MS or NMOSD. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.